MENU
HRMY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Harmony Biosciences Holdings (HRMY) Earnings Date & Reports

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs... Show more

A.I. Advisor
published Earnings

HRMY is expected to report earnings to fall 29.70% to 72 cents per share on August 12

Harmony Biosciences Holdings HRMY Stock Earnings Reports
Q2'25
Est.
$0.72
Q1'25
Beat
by $0.42
Q4'24
Beat
by $0.39
Q3'24
Beat
by $0.12
Q2'24
Beat
by $1.04
The last earnings report on May 06 showed earnings per share of $1.03, beating the estimate of 61 cents. With 673.38K shares outstanding, the current market capitalization sits at 1.98B.
View a ticker or compare two or three
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com